Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Relations CareersResearchLicensingThe Merck Manuals

The Merck Manual of Geriatrics logo
red line
click here to go to the Contents page of The Merck Manual of Geriatrics
click here to go to the title page of The Merck Manual of Geriatrics
click here to search The Merck Manual of Geriatrics
click here to go to the Index of The Merck Manual of Geriatrics
red line
Section 9. Hematologic Disorders and Cancer
Chapter 73. Hematologic Malignancies
Topics:    Acute Leukemias | Chronic Leukemias | Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Waldenström's Macroglobulinemia | Myelodysplastic Syndromes

red line

Monoclonal Gammopathy of Undetermined Significance

The presence of M protein in the serum or urine of asymptomatic, apparently healthy persons.

Monoclonal gammopathy of undetermined significance--usually a benign disorder--is a likely diagnosis in a patient with elevated serum levels of monoclonal protein but with no other symptoms and neither osteolytic lesions nor plasma cell infiltration. Confirming findings for this diagnosis include no significant amounts (ie, < 60 mg/24 hours) of a single type of light chain (ie, Bence Jones protein) in the urine and serum levels of monoclonal protein < 2 g/dL.

Only time will determine if a diagnosis of monoclonal gammopathy of undetermined significance is really early multiple myeloma. Over 20 years, about 25% of patients initially diagnosed with monoclonal gammopathy develop overt multiple myeloma or other lymphoproliferative lesions. No evidence indicates that not treating these patients is harmful.

Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.